Hostname: page-component-77c89778f8-7drxs Total loading time: 0 Render date: 2024-07-21T08:34:26.076Z Has data issue: false hasContentIssue false
  • English
  • Français

The Mini Nutritional Assessment combined with body fat for detecting the risk of sarcopenia and sarcopenic obesity in metabolic syndrome

Published online by Cambridge University Press:  05 February 2024

Chi-Hua Yen ,
Yi-Wen Lee ,
Wei-Jung Chang  and
Ping-Ting Lin Open the ORCID record for Ping-Ting Lin [Opens in a new window]
Chi-Hua Yen
Affiliation:
School of medicine, Chung Shan Medical University, Taichung 402367, Taiwan Department of Family and Community Medicine, Chung Shan Medical University Hospital, Taichung 402367, Taiwan
Yi-Wen Lee
Affiliation:
Department of Nutrition, Chung Shan Medical University, Taichung 402367, Taiwan
Wei-Jung Chang
Affiliation:
Department of Nutrition, Chung Shan Medical University, Taichung 402367, Taiwan
Ping-Ting Lin*
Affiliation:
Department of Nutrition, Chung Shan Medical University, Taichung 402367, Taiwan Department of Nutrition, Chung Shan Medical University Hospital, Taichung 402367, Taiwan
*
*Corresponding author: Ping-Ting Lin, email [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Malnutrition is a key factor in metabolic syndrome (MS) and sarcopenia, assessing the nutritional status of these patients is a pressing issue. The purpose of this study was to clarify sarcopenia and sarcopenic obesity in patients with MS based on nutritional status. This was a case–control study between MS/non-MS. Body composition was measured by dual-energy X-ray absorptiometry. Muscle function was assessed by handgrip strength, five times sit-to-stand test, gait speed test and short physical performance battery (SPPB). The Mini Nutritional Assessment (MNA) was performed to assess the nutritional status in the participants in this study. Overall, a total of 56 % and 13 % of participants suffered from possible sarcopenia and sarcopenia, respectively. There was a higher rate of possible sarcopenic obesity in the MS group than in the non-MS group (48·9 % v. 24·7 %, P < 0·01), and all the sarcopenia participants in the MS group had sarcopenic obesity. MNA score was significantly associated with sarcopenia status (P < 0·01). The MNA combined with body fat score showed better acceptable discrimination for detecting sarcopenic obesity and sarcopenia in MS (AUC = 0·70, 95 % CI 0·53, 0·86). In summary, there was a higher prevalence of possible sarcopenic obesity in MS, and all the MS patients with sarcopenia had sarcopenic obesity in the present study. We suggest that the MNA should be combined with body fat percentage to assess the nutritional status of MS participants, and it also serves as a good indicator for sarcopenia and sarcopenic obesity in MS.

Keywords

Mini Nutritional AssessmentSarcopeniaSarcopenic obesityMetabolic syndromeAnthropometry
Type
Research Article
Information
British Journal of Nutrition , Volume 131 , Issue 10 , 28 May 2024 , pp. 1659 - 1667
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mottillo, S, Filion, KB, Genest, J, et al. (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56, 1113–1132.CrossRefGoogle ScholarPubMed
Noubiap, JJ, Nansseu, JR, Lontchi-Yimagou, E, et al. (2022) Geographic distribution of metabolic syndrome and its components in the general adult population: a meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract 188, 109924.CrossRefGoogle ScholarPubMed
Yang, C, Jia, X, Wang, Y, et al. (2022) Trends and influence factors in the prevalence, intervention, and control of metabolic syndrome among US adults, 1999–2018. BMC Geriatr 22, 979.CrossRefGoogle ScholarPubMed
Health Promotion Administration & Ministry of Health and Welfare (2022) Report of the 2017–2020 Nutrition and Health Survey in Taiwan. https://www.hpa.gov.tw/File/Attach/15562/File_18775.pdf (accessed 16 October 2023).Google Scholar
Liu, ZJ & Zhu, CF (2023) Causal relationship between insulin resistance and sarcopenia. Diabetol Metab Syndr 15, 46.CrossRefGoogle ScholarPubMed
Choi, KM (2016) Sarcopenia and sarcopenic obesity. Korean J Intern Med 31, 1054–1060.CrossRefGoogle ScholarPubMed
Sayer, AA & Cruz-Jentoft, A (2022) Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing 51, afac220.CrossRefGoogle Scholar
Petermann-Rocha, F, Balntzi, V, Gray, SR, et al. (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13, 86–99.CrossRefGoogle ScholarPubMed
Petermann-Rocha, F, Ho, FK, Welsh, P, et al. (2020) Physical capability markers used to define sarcopenia and their association with cardiovascular and respiratory outcomes and all-cause mortality: a prospective study from UK Biobank. Maturitas 138, 69–75.CrossRefGoogle ScholarPubMed
Heo, M, Faith, MS, Pietrobelli, A, et al. (2012) Percentage of body fat cutoffs by sex, age, and race-ethnicity in the US adult population from NHANES 1999–2004. Am J Clin Nutr 95, 594–602.CrossRefGoogle ScholarPubMed
Donini, LM, Busetto, L, Bischoff, SC, et al. (2022) Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts 15, 321–335.CrossRefGoogle ScholarPubMed
Gao, Q, Mei, F, Shang, Y, et al. (2021) Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr 40, 4633–4641.CrossRefGoogle ScholarPubMed
Batsis, JA, Mackenzie, TA, Emeny, RT, et al. (2017) Low lean mass with and without obesity, and mortality: results from the 1999–2004 National Health and Nutrition Examination Survey. J Gerontol A Biol Sci Med Sci 72, 1445–1451.CrossRefGoogle ScholarPubMed
Batsis, JA & Villareal, DT (2018) Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 14, 513–537.CrossRefGoogle ScholarPubMed
Xie, WQ, Xiao, GL, Fan, YB, et al. (2021) Sarcopenic obesity: research advances in pathogenesis and diagnostic criteria. Aging Clin Exp Res 33, 247–252.CrossRefGoogle ScholarPubMed
Chen, LK, Arai, H, Assantachai, P, et al. (2022) Roles of nutrition in muscle health of community-dwelling older adults: evidence-based expert consensus from Asian Working Group for Sarcopenia. J Cachexia Sarcopenia Muscle 13, 1653–1672.CrossRefGoogle ScholarPubMed
Therakomen, V, Petchlorlian, A & Lakananurak, N (2020) Prevalence and risk factors of primary sarcopenia in community-dwelling outpatient elderly: a cross-sectional study. Sci Rep 10, 19551.CrossRefGoogle ScholarPubMed
Kramer, CS, Groenendijk, I, Beers, S, et al. (2022) The association between malnutrition and physical performance in older adults: a systematic review and meta-analysis of observational studies. Curr Dev Nutr 6, nzac007.CrossRefGoogle Scholar
Papadopoulou, SK (2020) Sarcopenia: a contemporary health problem among older adult populations. Nutrients 12, 1293.CrossRefGoogle ScholarPubMed
Dent, E, Wright, ORL, Woo, J, et al. (2023) Malnutrition in older adults. Lancet 401, 951–966.CrossRefGoogle ScholarPubMed
Health Promotion Administration & Ministry of Health and Welfare (2007) Criteria for Metabolic Syndrome in Adults (Over 20 Years Old) (2007 Taiwan). https://www.hpa.gov.tw/Pages/Detail.aspx?nodeid=639&pid=1219 (accessed 16 October 2023).Google Scholar
Ware, J Jr, Kosinski, M & Keller, SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34, 220–233.CrossRefGoogle ScholarPubMed
Vellas, B, Villars, H, Abellan, G, et al. (2006) Overview of the MNA--its history and challenges. J Nutr Health Aging 10, 456–463; discussion 463–465.Google ScholarPubMed
Fried, LP, Tangen, CM, Walston, J, et al. (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56, M146–M156.CrossRefGoogle ScholarPubMed
Guralnik, JM, Simonsick, EM, Ferrucci, L, et al. (1994) A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 49, M85–M94.CrossRefGoogle Scholar
Chen, LK, Woo, J, Assantachai, P, et al. (2020) Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc 21, 300–307.CrossRefGoogle Scholar
Park, SJ, Ryu, SY, Park, J, et al. (2019) Association of Sarcopenia with metabolic syndrome in Korean population using 2009–2010 Korea National Health and Nutrition Examination Survey. Metab Syndr Relat Disord 17, 494–499.CrossRefGoogle ScholarPubMed
Beavers, KM, Hsu, FC, Houston, DK, et al. (2013) The role of metabolic syndrome, adiposity, and inflammation in physical performance in the Health ABC Study. J Gerontol A Biol Sci Med Sci 68, 617–623.CrossRefGoogle ScholarPubMed
Liu, C, Wong, PY, Chung, YL, et al. (2023) Deciphering the ‘obesity paradox’ in the elderly: a systematic review and meta-analysis of sarcopenic obesity. Obes Rev 24, e13534.CrossRefGoogle ScholarPubMed
Cleasby, ME, Jamieson, PM & Atherton, PJ (2016) Insulin resistance and sarcopenia: mechanistic links between common co-morbidities. J Endocrinol 229, R67–R81.CrossRefGoogle ScholarPubMed
de Luis Roman, DA & Lopez Gomez, JJ (2023) Morphofunctional nutritional assessment in clinical practice: a new approach to assessing nutritional status. Nutrients 15, 4300.CrossRefGoogle ScholarPubMed
García Almeida, JM, García García, C, Vegas Aguilar, IM, et al. (2021) Morphofunctional assessment of patient´s nutritional status: a global approach. Nutr Hosp 38, 592–600.Google ScholarPubMed
Liguori, I, Curcio, F, Russo, G, et al. (2018) Risk of malnutrition evaluated by mini nutritional assessment and sarcopenia in noninstitutionalized elderly people. Nutr Clin Pract 33, 879–886.CrossRefGoogle ScholarPubMed